Viewing Study NCT03222167


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-04-21 @ 11:30 AM
Study NCT ID: NCT03222167
Status: UNKNOWN
Last Update Posted: 2017-08-07
First Post: 2017-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
Sponsor: Institute Of Cardiology & Internal Diseases, Kazakhstan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module